|
Zinc dysregulation as a druggable target in human skin photocarcinogenesis
|
1R03CA230949-01
|
$73,677
|
|
WONDRAK, GEORG
|
UNIVERSITY OF ARIZONA
|
|
Young Empowered Scientists for ContinUed Research Engagement (YES for CURE)
|
5R25CA221738-02
|
$409,851
|
|
DECAPRIO, JAMES
|
DANA-FARBER CANCER INST
|
|
Yale SPORE in Skin Cancer
|
2P50CA121974-11A1
|
$2,500,000
|
|
BOSENBERG, MARCUS
|
YALE UNIVERSITY
|
|
Yale Cancer Center NCTN
|
3U10CA180826-03S1
|
$49,901
|
$2,495
|
HOCHSTER, HOWARD
|
YALE UNIVERSITY
|
|
Yale Cancer Center NCTN
|
5U10CA180826-04
|
$951,500
|
$47,575
|
HOCHSTER, HOWARD
|
YALE UNIVERSITY
|
|
Womens Interagency HIV Study (WIHS-V)
|
3U01AI035004-25S1
|
$144,370
|
|
ANASTOS, KATHRYN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Winship Cancer Institute, National Clinical Trials Network Lead Academic Particip
|
5U10CA180864-04
|
$542,798
|
$20,355
|
RAMALINGAM, SURESH
|
EMORY UNIVERSITY
|
|
WEE1 inhibition and tumor immunity
|
1R01CA222963-01A1
|
$446,500
|
|
ZHANG, BIN
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Washington Womens Interagency HIV/AIDS Study
|
3U01AI034994-24S1
|
$106,140
|
|
KASSAYE, SEBLE
|
GEORGETOWN UNIVERSITY
|
|
Vitamin D Deficiency Leads to Increased Intra-Prostatic Androgens in African American Men
|
1R21CA231610-01
|
$208,670
|
|
NONN, LARISA
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
|
Vitamin D and HA Signaling in TNBC
|
3R01CA194500-04S1
|
$51,381
|
|
WELSH, JOELLEN
|
STATE UNIVERSITY OF NEW YORK AT ALBANY
|
|
Vitamin D and HA Signaling in TNBC
|
3R01CA194500-04S2
|
$57,310
|
|
WELSH, JOELLEN
|
STATE UNIVERSITY OF NEW YORK AT ALBANY
|
|
VIMORTP (Vanderbilt Integrated Molecular Oncology Research Training Program)
|
1T32CA217834-01A1
|
$241,750
|
|
RATHMELL, W
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
VDAC Regulation of Warburg Metabolism in Hepatocarcinoma
|
3R01CA184456-03S2
|
$65,611
|
|
MALDONADO, EDUARDO
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
Vanderbilt Network Lead Academic Participating Site for the NCTN
|
5U10CA180847-05
|
$592,247
|
$29,612
|
BERLIN, JORDAN
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Validation of Siglec-6 as a novel target for cancer immunotherapy
|
1R21CA229961-01
|
$246,464
|
|
RADER, CHRISTOPH
|
SCRIPPS FLORIDA
|
|
Validation and Advanced Development of Albumin Oxidizability as a Marker of Plasma/Serum Integrity
|
1R33CA217702-01A1
|
$364,966
|
|
BORGES, CHAD
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
Validating and targeting USP35 for anticancer drug development
|
1U01CA222958-01A1
|
$349,766
|
|
LIU, CHANGWEI
|
UNIVERSITY OF COLORADO DENVER
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-43S1
|
$125,000
|
$8,750
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-43S2
|
$31,772
|
$2,224
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-43
|
$4,288,496
|
$300,195
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Utilizing Precision Medicine to elucidate the mechanisms underpinning treatment efficacy
|
1K99CA230384-01
|
$107,860
|
|
HOPKINS, BENJAMIN
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
Utilizing MEK Inhibition to Sensitize Microsatellite Stable Colorectal Cancer to Immune Checkpoint Therapy
|
1R01CA229259-01
|
$247,340
|
|
LIEU, CHRISTOPHER
|
UNIVERSITY OF COLORADO DENVER
|
|
UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10
|
3U10CA180870-03S1
|
$50,000
|
$1,250
|
GERBER, DAVID
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10
|
5U10CA180870-04
|
$700,000
|
$17,500
|
GERBER, DAVID
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP)
|
5U10CA180858-04
|
$688,299
|
$17,207
|
ENG, CATHY
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Using patient-derived models to understand drug responses in SCLC
|
1U01CA220323-01A1
|
$619,923
|
|
DYSON, NICHOLAS
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Using Functional Genomics to Inform Gene Environment Interactions for Colorectal Cancer
|
3R01CA201407-02S1
|
$32,686
|
|
PETERS, ULRIKE
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Using Community-Engaged Methods to Design a Tool to Promote Informed Breast Cancer Screening Decisions for Low Literacy Women
|
1K07CA221899-01A1
|
$129,704
|
|
GUNN, CHRISTINE
|
BOSTON MEDICAL CENTER
|
|
Using a Mixed Methods Approach to Understand Shared Decision-Making in Lung Cancer Screening
|
1R01CA222090-01A1
|
$558,179
|
|
CARTER-HARRIS, LISA
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Urologic Oncology Research Training Grant
|
5T32CA082088-18
|
$292,379
|
$43,857
|
CARVER, BRETT
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Urologic Oncology Branch Consult Core
|
ZID BC 011092
|
$1,788,723
|
$715,489
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Unraveling the Complexities of Risk and Mechanism in Cancer
|
1R35CA220523-01A1
|
$978,294
|
|
QUACKENBUSH, JOHN
|
HARVARD SCHOOL OF PUBLIC HEALTH
|
|
Unmasking targetable dependencies in cancer with intrinsic or acquired resistance to anti-cancer therapies
|
5F99CA222728-02
|
$35,610
|
|
ANDERSON, GRACE
|
DUKE UNIVERSITY
|
|
University of North Carolina Womens Interagency HIV Study UNC WIHS
|
3U01AI103390-05S1
|
$60,652
|
|
ADIMORA, ADAORA
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-28S3
|
$6,166,044
|
$61,660
|
FEARON, ERIC
|
UNIVERSITY OF MICHIGAN
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-28S4
|
$50,000
|
$500
|
FEARON, ERIC
|
UNIVERSITY OF MICHIGAN
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-28S5
|
$30,973
|
$310
|
FEARON, ERIC
|
UNIVERSITY OF MICHIGAN
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
2P30CA177558-06
|
$2,152,710
|
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
University of Hawaii Cancer Center CCSG
|
2P30CA071789-18
|
$1,913,800
|
|
HOLCOMBE, RANDALL
|
UNIVERSITY OF HAWAII AT MANOA
|
|
University of Colorado NTCN Lead Academic Participating Site (LAPS)
|
5U10CA180834-04
|
$768,950
|
$38,448
|
ELIAS, ANTHONY
|
UNIVERSITY OF COLORADO DENVER
|
|
Understanding Wnt5a regulation of protein depalmitoylation during cell migration
|
3R01CA181633-05S1
|
$69,420
|
|
WITZE, ERIC
|
UNIVERSITY OF PENNSYLVANIA
|
|
Understanding the one-two punch: biomarkers of clinical response to a novel compensatory drug combination for metastatic TNBC
|
1R21CA229951-01
|
$171,281
|
|
RADOVICH, MILAN
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
|
Understanding the mechanisms of immune suppression in lymph node metastases
|
1K22CA230315-01
|
$200,880
|
|
JONES, DENNIS
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
Understanding T Cell Rapamycin Resistance
|
ZIA BC 011220
|
$272,402
|
$54,480
|
Fowler, Daniel
|
CCR (NCI)
|
|
Understanding sex differences in colon cancer metabolism
|
1R21CA223686-01A1
|
$182,156
|
|
JOHNSON, CAROLINE
|
YALE UNIVERSITY
|
|
Understanding neuropsychological and psychosocial sequelae in the elderly and in adolescent and young adult cancer survivors
|
5F99CA222742-02
|
$31,397
|
|
WILLIAMS, ANNALYNN
|
UNIVERSITY OF ROCHESTER
|
|
Understanding Ikaros molecular functions for targeted therapies of pre-B ALL
|
1R01CA230618-01
|
$373,355
|
|
SCHJERVEN, HILDE
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Understanding Ethnic Differences in Cancer: The Multiethnic Cohort Study
|
5U01CA164973-07
|
$3,418,975
|
|
LE MARCHAND, LOIC
|
UNIVERSITY OF HAWAII AT MANOA
|
|
Understanding causal effects of a treatment on survival in observational studies with unmeasured confounding and an application to effect of PMRT on breast cancer patients
|
5R03CA208387-02
|
$88,836
|
|
YANG, FAN
|
UNIVERSITY OF COLORADO DENVER
|
Total relevant funding to Kidney Cancer for this search: $48,644,536
|